Profil
David A. Lehman currently works at Modernizing Medicine, Inc., as Senior Principal Medical Director, Blue Sea Capital Management LLC, as Executive Advisor, and ENT & Allergy Associates of Florida, as Partner from 2015.
Dr. Lehman received his undergraduate degree from Yale University and graduate degree from the University of Florida College of Medicine.
Postes actifs de David Lehman
| Sociétés | Poste | Début |
|---|---|---|
Blue Sea Capital Management LLC
Blue Sea Capital Management LLC Investment ManagersFinance Blue Sea Capital invests in lower middle market companies located in the United States with an EBITDA of USD 5-30 million and enterprise value USD 30-300 million. The firm targets companies operating in the fields of aerospace and defense, healthcare, and industrial growth sectors with an investment size of USD 30-150 million. It provides financing for buyout transactions and acquires both majority and minority interests. | Consultant / Advisor | - |
Modernizing Medicine, Inc.
Modernizing Medicine, Inc. Packaged SoftwareTechnology Services Operates as a healthcare technology company that develops cloud-based software to support the clinical, financial and operational workflows of specialty medical practices | Directeur/Membre du Conseil | - |
Formation de David Lehman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Modernizing Medicine, Inc.
Modernizing Medicine, Inc. Packaged SoftwareTechnology Services Operates as a healthcare technology company that develops cloud-based software to support the clinical, financial and operational workflows of specialty medical practices | Technology Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blue Sea Capital Management LLC
Blue Sea Capital Management LLC Investment ManagersFinance Blue Sea Capital invests in lower middle market companies located in the United States with an EBITDA of USD 5-30 million and enterprise value USD 30-300 million. The firm targets companies operating in the fields of aerospace and defense, healthcare, and industrial growth sectors with an investment size of USD 30-150 million. It provides financing for buyout transactions and acquires both majority and minority interests. | Finance |
University of Florida College of Medicine
University of Florida College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















